PapersPMID:36999358
Efficacy and safety of Ginkgo biloba extract as an adjuvant in the treatment of Chinese patients with sudden hearing loss: a meta-analysis.
What moved
1 findingHow to read these marks →“The patients in the experimental group showed a higher total effective rate than those in the control group (RR = 1.21, 95% CI: 1.17–1.26, p < 0.00001).”
- Study
- meta-analysis
- Effect
- 1.21 risk ratio, 95% CI 1.17 to 1.26
- Dose studied
- 70 to 140 mg/day in most trials, courses of 10 or 14 days
- Population
- Patients with sudden hearing loss; 27 pooled randomised trials, Ginkgo biloba extract plus general treatment against general treatment alone
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Chinese patients with sudden hearing loss in 27 randomized trials; Ginkgo biloba extract (oral or injection, various manufacturers) added to general treatments versus general treatments alone
- Participants
- 2,623
- Comparator
- an active treatment / no treatment
- Duration
- not reported
- Endpoints measured
- 23